1196486-69-7

Basic information

• Product Name: tert-butyl 4-hydrazino-piperidine-1-carboxylate
• Synonyms: tert-butyl 4-hydrazino-piperidine-1-carboxylate
• CAS NO: 1196486-69-7
• Molecular Weight: 215.296
• Mol File: 1196486-69-7.mol

Chemical Properties

• Boiling Point: 333.8±31.0 °C(Predicted)
• Density: 1.08±0.1 g/cm3(Predicted)
• CAS DataBase Reference: tert-butyl 4-hydrazino-piperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-hydrazino-piperidine-1-carboxylate(1196486-69-7)
• EPA Substance Registry System: tert-butyl 4-hydrazino-piperidine-1-carboxylate(1196486-69-7)

Safety Data

• Hazardous Substances Data: 1196486-69-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Tert-butyl 4-hydrazino-piperidine-1-carboxylate is used as a key intermediate in the synthesis of new anti-cancer agents. Its unique chemical structure allows for the development of compounds that can target and inhibit the growth of cancer cells, offering potential therapeutic benefits in cancer treatment.
Used in Anti-inflammatory Applications:
tert-butyl 4-hydrazino-piperidine-1-carboxylate is also utilized in the creation of anti-inflammatory drugs. Its chemical properties enable the design of molecules that can modulate inflammatory responses, providing relief from inflammation and associated symptoms.
Used in Neurological Disorder Treatment:
Tert-butyl 4-hydrazino-piperidine-1-carboxylate has shown promise in the development of treatments for neurological disorders. Its potential applications in this area stem from its ability to interact with specific biological targets, offering avenues for the treatment of conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis.
Used in Medicinal Chemistry Research:
As a versatile building block, tert-butyl 4-hydrazino-piperidine-1-carboxylate is used in medicinal chemistry research to explore its potential in the synthesis of biologically active compounds. Its unique structure and properties make it an important tool for the development of innovative therapeutic agents.

Upstream product

• 1201943-52-3 C₁₀H₁₉N₃O₂ 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 7803-57-8 hydrazine hydrate 

Downstream Products

• 503148-99-0 4-(3,5-diphenyl-1-pyrazolyl)piperidine 
• 877399-74-1 tert-butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate 
• 1205637-27-9 tert-butyl 4-(4-phenyl-1H-pyrazol-1-yl)piperidine-1-carboxylate 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS, PREPARATION METHODS THEREFOR, AND METHODS OF USES THEREOF

Provided herein are novel heterocyclic compounds, for example, compounds having Formula I. Also provided herein are methods of preparing the compounds and methods of using the same, for example, in inhibiting TGF-beta mediated signaling and/or for treating cancer.

5-MEMBERED HETEROCYCLE FUSED WITH [3,4-D]PYRIDAZINONE, AND MANUFACTURING METHOD, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF

The present invention provides a compound comprising a 5-membered heterocycle fused with a pyridazinone, wherein the compound is used as an FGFR kinase inhibitor, and a manufacturing method and application thereof. The invention specifically provides a co

PYRAZOLE DERIVATIVES AS NHIBITORS OF THE WNT SIGNALLING PATHWAY

The present invention relates to a novel class of compounds as inhibitors of the Wnt signalling pathway. The best compounds showed potencies in the low micromolar range and high efficacies (> 80%) together with good microsomal stability. Furthermore, in v

Synthesis of 1 - (N - Boc - 4 - piperidyl) - 4 - pyrazole boric acid frequency alcohol ester

The invention discloses a method for synthesis of 1-(N-Boc-4-piperidine)-4-pyrazoleboronic acid pinaol ester. According to the method, N-Boc-4-piperidone serves as the raw material and reacts with hydrazine hydrate, N-Boc-4-piperidine hydrazine is generated through reduction, then dehydration condensation reaction is conducted between N-Boc-4-piperidine hydrazine and 2-halogenate malonaldehyde so that a 1-(N-Boc-4-piperidine)-4-chlorine/bromine pyrazol midbody can be obtained effectively, and in the presence of metallic nickel, metallic nickel catalytic coupling reaction ester forming is conducted on the midbody under a mild condition to obtain the 1-(N-Boc-4-piperidine)-4-pyrazoleboronic acid pinaol ester. The whole process is easy to operate, conditions are mild, and untralow-temperature reaction is not needed; meanwhile, required raw materials are cheap and easy to obtain, reproducibility is high, and the method is suitable for industrialized large-scale production.

NOVEL PIPERIDINE DERIVATIVES

The invention relates to a compound of formula (I) wherein A1, A2 and R1to R3 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.

BICYCLIC HETEROCYCLE DERIVATIVES AND THEIR USE AS GPCR MODULATORS

The present invention relates to Bicyclic Heterocycle Derivatives of Formula (I), compositions comprising a Bicyclic Heterocycle Derivative, and methods of using the Bicyclic Heterocycle Derivatives for treating or preventing obesity, diabetes, a diabetic

GPR119 Receptor Agonists

Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.